Benzinga | Aug 5, 2021 07:35AM EDT

Baudax Bio Q2 EPS $(0.21) Misses $(0.20) Estimate, Sales $201.00K Miss $470.00K Estimate

Baudax Bio (NASDAQ:BXRX) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.20) by 5 percent. This is a 87.79 percent increase over losses of $(1.72) per share from the same period last year. The company reported quarterly sales of $201.00 thousand which missed the analyst consensus estimate of $470.00 thousand by 57.23 percent. This is a 42.41 percent decrease over sales of $349.00 thousand the same period last year.